Advertisement

Topics

Compugen Ltd. Company Profile

16:05 EDT 22nd April 2018 | BioPortfolio

Compugen is a leading drug and diagnostic product candidate discovery company. Unlike traditional high throughput trial and error experimental based discovery, Compugen's discovery efforts are based on in silico (by computer) prediction and selection utilizing a growing number of field focused proprietary discovery platforms accurately modeling biological processes at the molecular level. Compugen's growing number of collaborations with major pharmaceutical and diagnostic companies cover both (i) the licensing of product candidates discovered by Compugen during the validation of its discovery platforms and in its internal research, and (ii) 'discovery on demand' agreements where existing or new Compugen discovery platforms are utilized to predict and select product candidates as required by a partner. In 2002, Compugen established an affiliate, Evogene Ltd. (www.evogene.com) (TASE: EVGN), to utilize certain of the Company's 'in silica' predictive discovery capabilities in agricultural biotechnology. For additional information, please visit Compugen's corporate website at: www.cgen.com.


News Articles [30 Associated News Articles listed on BioPortfolio]

MedImmune to Develop Compugen Immuno-Oncology Antibodies

AstraZeneca’s MedImmune subsidiary has agreed to exclusively license and develop bi-specific and multi-specific immuno-oncology antibody products from Compugen’s pipeline, through a collaboration ...

Compugen inks I-O deal worth over $210 million with AZ unit

Compugen has entered into an exclusive license agreement with MedImmune.

AZ signs up for access to Compugen’s pipeline

AstraZeneca’s MedImmune has inked a deal with Israeli group Compugen giving it access to the firm’s experimental bi- and multi-specific antibody products.

Compugen and MedImmune enter exclusive license agreement

MedImmune LLC and Compugen Ltd. penned an agreement for the development of bispecific and multi-specific antibody therapies for cancer.

Compugen and MedImmune Strike Oncology Development Deal Worth up to $200 million

Israel-based drug maker Compugen Ltd. and pharma giant AstraZeneca have teamed up to develop bi-specific and multi-specific immuno-oncology antibody products.

Compugen licenses Selexis cell line tech

Compugen has selected Selexisâ SUREtechnology cell expression platform to generate high-performance research cell banks (RCBs) and support its antibody pipeline.

Compugen Has Licensed Selexis’ Cell Line-Based Protein Expression Platform for the ...

Selexis SUREtechnology Platform™ in use for the generation of high-performance research cell banks for Compugen Read more...

MedImmune, Compugen sign immuno-oncology deal

Compugen has signed an exclusive license agreement with AstraZeneca’s subsidiary MedImmune for the development of bi-specific and multi-specific immuno-oncology antibody products.

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [5 Associated Companies listed on BioPortfolio]

Compugen Ltd.

Compugen is a leading drug and diagnostic product candidate discovery company. Unlike traditional high throughput trial and error experimental based discovery, Compugen's discovery efforts are b...

Compugen

Compugen is a leading drug and diagnostic product candidate discovery company. Unlike traditional high throughput trial and error experimental based discovery, Compugen’s discovery efforts are based...

Compugen Ltd. Compugen Ltd.

Compugen is a leading therapeutic product discovery company focused on therapeutic proteins and monoclonal antibodies to address important unmet needs in the fields of immunology ...

Neviah Genomics

Neviah Genomics was jointly established in 2012 by Merck Serono, the biopharmaceutical business of Merck, and Compugen Ltd. The company operates out of the MS Ventures’ Israe...

BioLineRx Ltd. and Compugen Ltd.

BioLineRx Ltd. is a publicly-traded biopharmaceutical development company. It is dedicated to building a portfolio of products for unmet medical needs or with advantages over curr...

More Information about "Compugen Ltd." on BioPortfolio

We have published hundreds of Compugen Ltd. news stories on BioPortfolio along with dozens of Compugen Ltd. Clinical Trials and PubMed Articles about Compugen Ltd. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Compugen Ltd. Companies in our database. You can also find out about relevant Compugen Ltd. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...


Corporate Database Quicklinks



Searches Linking to this Company Record